Vitamin D and overall mortality

Pigment Cell and Melanoma Research

Volumn 26, Issue 1, 2013, Pages 16-28

  Guerrieri Gonzaga, Aliana ^a   Gandini, Sara ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

25(OH)D; Cancer risk; Overall mortality; VDR; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

BREAST CANCER; CALCIUM INTAKE; CANCER MORTALITY; CANCER PATIENT; CHRONIC KIDNEY DISEASE; COLORECTAL CANCER; DISEASE ASSOCIATION; DRUG SAFETY; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MELANOMA; META ANALYSIS (TOPIC); NOTE; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT CANCER; RISK FACTOR; STOMACH CANCER; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; HUMANS; META-ANALYSIS AS TOPIC; MORTALITY; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D;

EID: 84871451856     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12036     Document Type: Note

References (138)

1. Abbas, S., Chang-Claude, J., and Linseisen, J. (2009). Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int. J. Cancer 124, 250-255.
2. Adams, J.S., and Lee, G. (1997). Gains in bone mineral density with resolution of vitamin D intoxication. Ann. Intern. Med. 127, 203-206.
3. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., Lappe, D.L., and Muhlestein, J.B. (2010). Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106, 963-968.
4. Autier, P., and Gandini, S. (2007). Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167, 1730-1737.
5. Autier, P., Gandini, S., and Mullie, P. (2012). A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J. Clin. Endocrinol. Metab. 97, 2613.
6. Avenell, A., Grant, A.M., McGee, M., McPherson, G., Campbell, M.K., and McGee, M.A. (2004). The effects of an open design on trial participant recruitment, compliance and retention-a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin. Trials 1, 490-498.
7. Avenell, A., Maclennan, G.S., Jenkinson, D.J. et al. (2012). Long-term follow-up for mortality and cancer in a Randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD Trial). J. Clin. Endocrinol. Metab. 97, 614-622.
8. Baeksgaard, L., Andersen, K.P., and Hyldstrup, L. (1998). Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporos. Int. 8, 255-260.
9. Bai, Y.H., Lu, H., Hong, D., Lin, C.C., Yu, Z., and Chen, B.C. (2012). Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J. Gastroenterol. 18, 1672-1679.
10. Barreto, D.V., Barreto, F.C., Liabeuf, S., Temmar, M., Boitte, F., Choukroun, G., Fournier, A., and Massy, Z.A. (2009). Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 1128-1135.
11. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T., and wson-Hughes, B. (2006). Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84, 18-28.
12. Bjelakovic, G., Gluud, L.L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R.G., Bjelakovic, M., and Gluud, C. (2011). Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 7, CD007470.
13. de Boer, I., Kestenbaum, B., Shoben, A.B., Michos, E.D., Sarnak, M.J., and Siscovick, D.S. (2009). 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 20, 1805-1812.
14. Bouillon, R., Moody, T., Sporn, M., Barrett, J.C., and Norman, A.W. (2005). NIH deltanoids meeting on vitamin D and cancer. Conclusion and strategic options. J. Steroid Biochem. Mol. Biol. 97, 3-5.
15. Bouillon, R., Carmeliet, G., Verlinden, L., van, E.E., Verstuyf, A., Luderer, H.F., Lieben, L., Mathieu, C., and Demay, M. (2008). Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776.
16. Brazier, M., Grados, F., Kamel, S., Mathieu, M., Morel, A., Maamer, M., Sebert, J.L., and Fardellone, P. (2005). Clinical and laboratory safety of 1 year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin. Ther. 27, 1885-1893.
17. Brozyna, A.A., Jozwicki, W., Janjetovic, Z., and Slominski, A.T. (2011). Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum. Pathol. 42, 618-631.
18. Brozyna, A.A., Jozwicki, W., Janjetovic, Z., and Slominski, A.T. (2012). Expression of the vitamin D-activating enzyme 1alpha-hydroxylase (CYP27B1) decreases during melanoma progression. Hum. Pathol. doi: 10.1016/j.humpath.2012.03.031.
19. Brunner, R.L., Wactawski-Wende, J., Caan, B.J., et al. (2011). The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr. Cancer 63, 827-841.
20. Calvo, M.S., Whiting, S.J., and Barton, C.N. (2005). Vitamin D intake: a global perspective of current status. J. Nutr. 135, 310-316.
21. Cawthon, P.M., Parimi, N., Barrett-Connor, E. et al. (2010). Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J. Clin. Endocrinol. Metab. 95, 4625-4634.
22. Chapuy, M.C., Arlot, M.E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., Delmas, P.D., and Meunier, P.J. (1992). Vitamin D3 and calcium to prevent hip fractures in the elderly women. N. Engl. J. Med. 327, 1637-1642.
23. Chapuy, M.C., Pamphile, R., Paris, E., Kempf, C., Schlichting, M., Arnaud, S., Garnero, P., and Meunier, P.J. (2002). Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos. Int. 13, 257-264.
24. Chlebowski, R.T., Johnson, K.C., Kooperberg, C., Pettinger, M., Wactawski-Wende, J., Rohan, T., Rossouw, J., Lane, D., O'Sullivan, M.J. et al. (2008). Calcium plus vitamin D supplementation and the risk of breast cancer. J. Natl Cancer Inst. 100, 1581-1591.
25. Cranney, A., Horsley, T., O'Donnell, S., Weiler, H., Puil, L., Ooi, D., Atkinson, S., Ward, L., Moher, D. et al. (2007). Effectiveness and safety of vitamin D in relation to bone health. Evid. Rep. Technol. Assess. (Full. Rep.), 158, 1-235.
26. Doorenbos, C.R., van den, B.J., Navis, G., and de Borst, M.H. (2009). Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat. Rev. Nephrol. 5, 691-700.
27. Drake, M.T., Maurer, M.J., Link, B.K., Habermann, T.M., Ansell, S.M., Micallef, I.N., Kelly, J.L., Macon, W.R., Nowakowski, G.S. et al. (2010). Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J. Clin. Oncol. 28, 4191-4198.
28. Drechsler, C., Pilz, S., Obermayer-Pietsch, B. et al. (2010). Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur. Heart J. 31, 2253-2261.
29. Drechsler, C., Verduijn, M., Pilz, S., Dekker, F.W., Krediet, R.T., Ritz, E., Wanner, C., Boeschoten, E.W., and Brandenburg, V. (2011). Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol. Dial. Transplant. 26, 1024-1032.
30. Durup, D., Jorgensen, H.L., Christensen, J., Schwarz, P., Heegaard, A.M., and Lind, B. (2012). A reverse j-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the copd study. J. Clin. Endocrinol. Metab. 97, 2644-2652.
31. Dusso, A.S., Brown, A.J., and Slatopolsky, E. (2005). Vitamin D. Am. J. Physiol. Renal. Physiol. 289, F8-F28.
32. Eaton, C.B., Young, A., Allison, M.A. et al. (2011). Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI). Am. J. Clin. Nutr. 94, 1471-1478.
33. Elamin, M.B., bu Elnour, N.O., Elamin, K.B. et al. (2011). Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 1931-1942.
34. Fang, F., Kasperzyk, J.L., Shui, I., Hendrickson, W., Hollis, B.W., Fall, K., Ma, J., Gaziano, J.M., Stampfer, M.J. et al. (2011). Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS ONE 6, e18625.
35. Fedirko, V., Riboli, E., Tjonneland, A. et al. (2012). Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol. Biomarkers Prev. 21, 582-593.
36. Fiscella, K., Winters, P., Tancredi, D., Hendren, S., and Franks, P. (2011). Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? Cancer 117, 1061-1069.
37. Flicker, L., MacInnis, R., and Stein, M. (2004). Should all older people in residential care receive vitamin D to prevent falls?results of a randomised trial. J. Bone Miner. Res., 19, s992004. (Abstract)
38. Freedman, D.M., Looker, A.C., Chang, S.C., and Graubard, B.I. (2007). Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst. 99, 1594-1602.
39. Freedman, D.M., Fuhrman, B., Graubard, B.I., and Chang, S.C. (2009). Vitamin D and cancer mortality. Cancer Epidemiol. Biomarkers Prev. 18, 359-360.
40. Freedman, D.M., Looker, A.C., Abnet, C.C., Linet, M.S., and Graubard, B.I. (2010). Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res. 70, 8587-8597.
41. Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M.J., Mullie, P., and Autier, P. (2011). Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 128, 1414-1424.
42. George, P.S., Pearson, E.R., and Witham, M.D. (2012). Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. 29, e142-e150.
43. Gepner, A.D., Ramamurthy, R., Krueger, D.C., Korcarz, C.E., Binkley, N., and Stein, J.H. (2012). A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS ONE 7, e36617.
44. Giovannucci, E. (2007). Can vitamin D reduce total mortality? Arch. Intern. Med. 167, 1709-1710.
45. Giovannucci, E., Liu, Y., Rimm, E.B., Hollis, B.W., Fuchs, C.S., Stampfer, M.J., and Willett, W.C. (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451-459.
46. Goodwin, P.J., Ennis, M., Pritchard, K.I., Koo, J., and Hood, N. (2009). Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J. Clin. Oncol. 27, 3757-3763.
47. Gracia-Iguacel, C., Gallar, P., Qureshi, A.R. et al. (2010). Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome. J Ren Nutr. 20, 359-367.
48. Grant, A.M., Avenell, A., Campbell, M.K., Francis, R.M. et al. (2005). Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365, 1621-1628.
49. Gugatschka, M., Kiesler, K., Obermayer-Pietsch, B., Groselj-Strele, A., Griesbacher, A., and Friedrich, G. (2011). Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur. Arch. Otorhinolaryngol. 268, 1201-1204.
50. Harwood, R.H., Sahota, O., Gaynor, K., Masud, T., and Hosking, D.J. (2004). A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NONOF) Study. Age Ageing 33, 45-51.
51. Hathcock, J.N., Shao, A., Vieth, R., and Heaney, R. (2007). Risk assessment for vitamin D. Am. J. Clin. Nutr. 85, 6-18.
52. Heist, R.S., Zhou, W., Wang, Z. et al. (2008). Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J. Clin. Oncol. 26, 5596-5602.
53. Hewison, M. (2012). An update on vitamin D and human immunity. Clin Endocrinol. (Oxf) 76, 315-325.
54. Holick, M.F. (2007). Vitamin D deficiency. N. Engl. J. Med. 357, 266-281.
55. Holick, M.F., and Chen, T.C. (2008). Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080S-1086S.
56. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., Murad, M.H., and Weaver, C.M. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911-1930.
57. Hutchinson, M.S., Grimnes, G., Joakimsen, R.M., Figenschau, Y., and Jorde, R. (2010). Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur. J. Endocrinol. 162, 935-942.
58. IARC Working Group. (2008). Vitamin D and cancer. www. iarc. fr 5
59. Institute of Medicine. (2010). Dietary reference intakes for calcium and vitamin D. www. iom. edu/reports/2010/Dietary-Reference-intake-for-calcium-and-vitamin-D. aspx
60. Jackson, R.D., LaCroix, A.Z., Gass, M., Wallace, R.B., Robbins, J., Lewis, C.E., Bassford, T., Beresford, S.A., Black, H.R. et al. (2006). Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 354, 669-683.
61. Jacobs, E.T., Thomson, C.A., Flatt, S.W. et al. (2011). Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am. J. Clin. Nutr. 93, 108-117.
62. Jassal, S.K., Chonchol, M., von, M.D., Smits, G., and Barrett-Connor, E. (2010). Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am. J. Med. 123, 1114-1120.
63. Jia, X., Aucott, L.S., and McNeill, G. (2007). Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br. J. Nutr. 98, 593-599.
64. Kidney Disease: Improving Global outcome (KDIGO) CKD-MBD Work Group. (2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 113(Suppl), S1-S130.
65. Kilkkinen, A., Knekt, P., Aro, A., Rissanen, H., Marniemi, J., Heliovaara, M., Impivaara, O., and Reunanen, A. (2009). Vitamin D status and the risk of cardiovascular disease death. Am. J. Epidemiol. 170, 1032-1039.
66. Komulainen, M., Kroger, H., Tuppurainen, M.T., Heikkinen, A.M., Alhava, E., Honkanen, R., Jurvelin, J., and Saarikoski, S. (1999). Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J. Clin. Endocrinol. Metab. 84, 546-552.
67. Koutkia, P., Chen, T.C., and Holick, M.F. (2001). Vitamin D intoxication associated with an over-the-counter supplement. N. Engl. J. Med. 345, 66-67.
68. Krause, R., Schober-Halstenberg, H.J., Edenharter, G., Haas, K., Roth, H.J., and Frei, U. (2012). Vitamin D status and mortality of German hemodialysis patients. Anticancer Res. 32, 391-395.
69. Krieg, M.A., Jacquet, A.F., Bremgartner, M., Cuttelod, S., Thiebaud, D., and Burckhardt, P. (1999). Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporos. Int. 9, 483-488.
70. Latham, N.K., Anderson, C.S., Lee, A., Bennett, D.A., Moseley, A., and Cameron, I.D. (2003). A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J. Am. Geriatr. Soc. 51, 291-299.
71. Lazzeroni, M., Serrano, D., Pilz, S., and Gandini, S. (2012). Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med. Chem., in press
72. Lips, P. (2001). Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22, 477-501.
73. Lips, P., Graafmans, W.C., Ooms, M.E., Bezemer, P.D., and Bouter, L.M. (1996). Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann. Intern. Med. 124, 400-406.
74. London, G.M., Guerin, A.P., Verbeke, F.H., Pannier, B., Boutouyrie, P., Marchais, S.J., and Metivier, F. (2007). Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18, 613-620.
75. Manson, J.E., Bassuk, S.S., Lee, I.M. et al. (2012). The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33, 159-171.
76. Mehrotra, R., Kermah, D., Budoff, M., Salusky, I.B., Mao, S.S., Gao, Y.L., Takasu, J., Adler, S., and Norris, K. (2008). Hypovitaminosis D in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1144-1151.
77. Mehrotra, R., Kermah, D.A., Salusky, I.B., Wolf, M.S., Thadhani, R.I., Chiu, Y.W., Martins, D., Adler, S.G., and Norris, K.C. (2009). Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 76, 977-983.
78. Meier, C., Woitge, H.W., Witte, K., Lemmer, B., and Seibel, M.J. (2004). Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J. Bone Miner. Res. 19, 1221-1230.
79. Melamed, M.L., Michos, E.D., Post, W., and Astor, B. (2008). 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629-1637.
80. Melamed, M.L., Astor, B., Michos, E.D., Hostetter, T.H., Powe, N.R., and Muntner, P. (2009). 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J. Am. Soc. Nephrol. 20, 2631-2639.
81. Meyer, H.E., Smedshaug, G.B., Kvaavik, E., Falch, J.A., Tverdal, A., and Pedersen, J.I. (2002). Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J. Bone Miner. Res. 17, 709-715.
82. Meyer, F., Liu, G., Douville, P., Samson, E., Xu, W., Adjei, A., and Bairati, I. (2011). Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int. J. Cancer 128, 1741-1746.
83. Mezawa, H., Sugiura, T., Watanabe, M., Norizoe, C., Takahashi, D., Shimojima, A., Tamez, S., Tsutsumi, Y., Yanaga, K. and Urashima, M. (2010). Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study. BMC. Cancer 10, 347.
84. Michaelsson, K., Baron, J.A., Snellman, G. et al. (2010). Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 92, 841-848.
85. Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., wson-Hughes, B., Eisman, J.A., El-Hajj, F.G., Josse, R.G., Lips, P. and Morales-Torres, J. (2009). IOF Committee of Scientific Advisors (CSA) Nutrition Working group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20, 1807-1820.
86. Moan, J., Porojnicu, A.C., Dahlback, A., and Setlow, R.B. (2008). Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc. Natl Acad. Sci. USA 105, 668-673.
87. Muscogiuri, G., Sorice, G.P., Ajjan, R., Mezza, T., Pilz, S., Prioletta, A., Scragg, R., Volpe, S.L., Witham, M.D., and Giaccari, A. (2012). Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr. Metab Cardiovasc. Dis. 22, 81-87.
88. Narang, N.K., Gupta, R.C., and Jain, M.K. (1984). Role of vitamin D in pulmonary tuberculosis. J. Assoc. Physicians India 32, 185-188.
89. Newton-Bishop, J.A., Beswick, S., Randerson-Moor, J. et al. (2009). Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J. Clin. Oncol. 27, 5439-5444.
90. Ng, K., Wolpin, B.M., Meyerhardt, J.A., Wu, K., Chan, A.T., Hollis, B.W., Giovannucci, E.L., Stampfer, M.J., Willett, W.C. and Fuchs, C.C. (2009). Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br. J. Cancer 101, 916-923.
91. Ng, K., Sargent, D.J., Goldberg, R.M., Meyerhardt, J.A., Green, E.M., Pitot, H.C., Hollis, B.W., Pollak, M.N., and Fuchs, C.S. (2011). Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J. Clin. Oncol. 29, 1599-1606.
92. Pardanani, A., Drake, M.T., Finke, C., Lasho, T.L., Rozell, S.A., Jimma, T., and Tefferi, A. (2011). Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies. Am. J. Hematol. 86, 1013-1016.
93. Pecovnik-Balon, B., Jakopin, E., Bevc, S., Knehtl, M., and Gorenjak, M. (2009). Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther. Apher. Dial. 13, 268-272.
94. Peterlik, M., and Cross, H.S. (2009). Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur. J. Clin. Nutr. 63, 1377-1386.
95. Peterlik, M., Grant, W.B., and Cross, H.S. (2009). Calcium, vitamin D and cancer. Anticancer Res. 29, 3687-3698.
96. Pilz, S., Dobnig, H., Winklhofer-Roob, B., Riedmuller, G., Fischer, J.E., Seelhorst, U., Wellnitz, B., Boehm, B.O., and Marz, W. (2008). Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol. Biomarkers Prev. 17, 1228-1233.
97. Pilz, S., Tomaschitz, A., Obermayer-Pietsch, B., Dobnig, H., and Pieber, T.R. (2009). Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 29, 3699-3704.
98. Pilz, S., Tomaschitz, A., Drechsler, C., Dekker, J.M., and Marz, W. (2010). Vitamin D deficiency and myocardial diseases. Mol. Nutr. Food Res. 54, 1103-1113.
99. Pilz, S., Iodice, S., Zittermann, A., Grant, W.B., and Gandini, S. (2011a). Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58, 374-382.
100. Pilz, S., Tomaschitz, A., Drechsler, C., Zittermann, A., Dekker, J.M., and Marz, W. (2011b). Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr. Drug Targets 12, 88-96.
101. Pilz, S., Tomaschitz, A., Marz, W. et al. (2011c). Vitamin D, cardiovascular disease and mortality. Clin Endocrinol. (Oxf) 75, 575-584.
102. Pilz, S., Tomaschitz, A., Ritz, E., Kienreich, K., Lerchbaum, E., Obermayer-Pietsch, B., Marz, W., Gandini, S., and Dekker, J.M. (2012). Vitamin D and cancer mortality: insights from prospective epidemiological studies. Anticancer Agents Med. Chem. 52, 230. in press
103. Pinczewski, J., and Slominski, A. (2010). The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms. Exp. Dermatol. 19, 860-864.
104. Pittas, A.G., Chung, M., Trikalinos, T., Mitri, J., Brendel, M., Patel, K., Lichtenstein, A.H., Lau, J., and Balk, E.M. (2010). Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307-314.
105. Porthouse, J., Cockayne, S., King, C. et al. (2005). Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330, 1003.
106. Raimondi, S., Johansson, H., Maisonneuve, P., and Gandini, S. (2009). Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 30, 1170-1180.
107. Ravani, P., Malberti, F., Tripepi, G., Pecchini, P., Cutrupi, S., Pizzini, P., Mallamaci, F., and Zoccali, C. (2009). Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 75, 88-95.
108. Ren, C., Qiu, M.Z., Wang, D.S., Luo, H.Y., Zhang, D.S., Wang, Z.Q., Wang, F.H., Li, Y.H., Zhou, Z.W. et al. (2012). Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J. Transl. Med. 10, 16.
109. Ross, A.C., Manson, J.E., Abrams, S.A. et al. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53-58.
110. Saliba, W., Barnett, O., Rennert, H.S., and Rennert, G. (2012). The risk of all-cause mortality is inversely related to serum 25(OH)D levels. J. Clin. Endocrinol. Metab., 97, 2792-2798.
111. Schleithoff, S.S., Zittermann, A., Tenderich, G., Berthold, H.K., Stehle, P., and Koerfer, R. (2006). Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 83, 754-759.
112. Schwalfenberg, G.K. (2011). A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 55, 96-108.
113. Semba, R.D., Houston, D.K., Ferrucci, L., Cappola, A.R., Sun, K., Guralnik, J.M., and Fried, L.P. (2009). Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr. Res. 29, 525-530.
114. Semba, R.D., Houston, D.K., Bandinelli, S., Sun, K., Cherubini, A., Cappola, A.R., Guralnik, J.M., and Ferrucci, L. (2010). Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64, 203-209.
115. Shanafelt, T.D., Drake, M.T., Maurer, M.J. et al. (2011). Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117, 1492-1498.
116. Shoenfeld, N., Amital, H., and Shoenfeld, Y. (2009). The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat. Clin. Pract. Rheumatol. 5, 99-105.
117. Slominski, A., Tobin, D.J., Shibahara, S., and Wortsman, J. (2004). Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84, 1155-1228.
118. Sokol, S.I., Tsang, P., Aggarwal, V., Melamed, M.L., and Srinivas, V.S. (2011). Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol. Rev. 19, 192-201.
119. Souberbielle, J.C., Body, J.J., Lappe, J.M. et al. (2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 9, 709-715.
120. Szulc, P., Claustrat, B., and Delmas, P.D. (2009). Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS study. Clin. Endocrinol. (Oxf) 71, 594-602.
121. Szyszka, P., Zmijewski, M.A., and Slominski, A.T. (2012). New vitamin D analogs as potential therapeutics in melanoma. Expert Rev. Anticancer Ther. 12, 585-599.
122. Tretli, S., Hernes, E., Berg, J.P., Hestvik, U.E., and Robsahm, T.E. (2009). Association between serum 25(OH)D and death from prostate cancer. Br. J. Cancer 100, 450-454.
123. Tretli, S., Schwartz, G.G., Torjesen, P.A., and Robsahm, T.E. (2012). Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 23, 363-370.
124. Trivedi, D.P., Doll, R., and Khaw, K.T. (2003). Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469.
125. Urashima, M., Segawa, T., Okazaki, M., Kurihara, M., Wada, Y., and Ida, H. (2010). Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91, 1255-1260.
126. Vieth, R. (2004). Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol., 89-90, 575-579.
127. Vieth, R., Kimball, S., Hu, A., and Walfish, P.G. (2004). Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr. J. 3, 8.
128. Visser, M., Deeg, D.J., Puts, M.T., Seidell, J.C., and Lips, P. (2006). Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am. J. Clin. Nutr. 84, 616-622.
129. Vrieling, A., Hein, R., Abbas, S., Schneeweiss, A., Flesch-Janys, D., and Chang-Claude, J. (2011). Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 13, R74.
130. Wactawski-Wende, J., Kotchen, J.M., Anderson, G.L., et al. (2006). Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684-696.
131. Wang, A.Y., Lam, C.W., Sanderson, J.E., Wang, M., Chan, I.H., Lui, S.F., Sea, M.M., and Woo, J. (2008a). Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am. J. Clin. Nutr. 87, 1631-1638.
132. Wang, T.J., Pencina, M.J., Booth, S.L., Jacques, P.F., Ingelsson, E., Lanier, K., Benjamin, E.J., D'Agostino, R.B., Wolf, M. and Vasan, R.S. (2008b). Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
133. Witham, M.D., Nadir, M.A., and Struthers, A.D. (2009). Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 27, 1948-1954.
134. Wolf, M., Shah, A., Gutierrez, O. et al. (2007). Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72, 1004-1013.
135. Yamshchikov, A.V., Desai, N.S., Blumberg, H.M., Ziegler, T.R., and Tangpricha, V. (2009). Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pract. 15, 438-449.
136. Zhang, Y., Kong, J., Deb, D.K., Chang, A., and Li, Y.C. (2010). Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J. Am. Soc. Nephrol. 21, 966-973.
137. Zhou, W., Heist, R.S., Liu, G. et al. (2007). Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J. Clin. Oncol. 25, 479-485.
138. Zittermann, A., Iodice, S., Pilz, S., Grant, W.B., Bagnardi, V., and Gandini, S. (2012). Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 95, 91-100.